Free Trial

REGENXBIO (RGNX) SEC Filings & 10K Form

REGENXBIO logo
$8.19 -0.32 (-3.76%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$8.20 +0.02 (+0.18%)
As of 08/1/2025 06:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
07/15/2025
4:12 PM
BlackRock Portfolio Management LLC (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G
07/03/2025
5:53 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
11:15 PM
REGENXBIO (Filer)
Form EFFECT
06/25/2025
3:15 PM
REGENXBIO (Filer)
Form 424B3
06/13/2025
4:19 PM
REGENXBIO (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/03/2025
3:30 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/03/2025
3:31 PM
Bennett Jean (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:31 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:32 PM
Glucksmann Alexandra (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
3:32 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
3:29 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/24/2025
7:59 AM
BlackRock, Inc. (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G/A
04/14/2025
11:15 PM
REGENXBIO (Filer)
Form EFFECT
04/04/2025
4:16 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
4:17 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/04/2025
4:17 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
6:02 PM
Malzahn Craig (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/13/2025
3:49 PM
REGENXBIO (Filer)
Form POS AM
03/13/2025
3:20 PM
REGENXBIO (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2025
2:07 PM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G/A
02/05/2025
6:49 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
01/31/2025
8:54 AM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/14/2025
4:19 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4/A
01/14/2025
6:08 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:45 PM
BlackRock, Inc. (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G
12/30/2024
3:09 PM
REGENXBIO (Subject)
Vasista Vittal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:12 PM
REGENXBIO (Filer)
Form 424B5
12/09/2024
3:45 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
11/06/2024
3:10 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:49 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
10:42 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
09/18/2024
4:03 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
4:04 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:00 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:20 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:58 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:38 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
China just unlocked Nvidia’s AI chips—what that means for you (Ad)

Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.

08/05/2024
5:39 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:41 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGNX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners